Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Selective Formation of Covalent Protein Heterodimers with an Unnatural Amino Acid
2011
The DNA-damage response in human biology and disease
2009 StandoutNature
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA
2007
A view on drug resistance in cancer
2019 StandoutNature
Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report
2007
Enzyme-Catalyzed Activation of Anticancer Prodrugs
2004
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
New treatment for acute myelogenous leukemia
2014
Prodrug Strategies in Anticancer Chemotherapy
2007
Linker Technologies for Antibody–Drug Conjugates
2013
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
MGMT: its role in cancer aetiology and cancer therapeutics
2004
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Severe Sepsis and Septic Shock
2013 Standout
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
2014
Antibody targeted drugs as cancer therapeutics
2006
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
2012
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Immunity, Inflammation, and Cancer
2010 Standout
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Malignant Gliomas in Adults
2008 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Pharmacogenetics of Cancer Therapy: Getting Personal
1998
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Tansley Review No. 111
2000 Standout
Repair of O6-alkylguanine by alkyltransferases
2000
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
2014
Arming antibodies: prospects and challenges for immunoconjugates
2005
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
2003
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
The use of antiviral agents for the management of severe influenza
2010
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
2004
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Acute Myeloid Leukemia
2015 Standout
Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
2001
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes
2008
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Electrochemiluminescence (ECL)
2004 Standout
Pulse and pulse reverse plating—Conceptual, advantages and applications
2007 Standout
Update on Avian Influenza A (H5N1) Virus Infection in Humans
2008
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Antibody therapy for acute myeloid leukaemia
2013
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
2006
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
2008
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Topoisomerase I inhibitors: selectivity and cellular resistance
1999
Metal–Organic Frameworks in Biomedicine
2011 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Intramolecular 1,3-dipolar nitrone cycloaddition route to bicyclic fused enediyne
2005
Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-α-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain
1995
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Immune Therapy for Cancer
2008
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Works of Sandip Kumar Roy being referenced
Human liver oxidative metabolism of O6-benzylguanine
1995
Superoxide generation by lipoxygenase in the presence of NADH and NADPH
1994
Activation of Macrocyclic Enediynes by Transannular Cyclization
2004
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
1998
Clinical pharmacology and pharmacogenetics of thiopurines
2008
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
1998
A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
2007
O6-Alkylguanine-DNA Alkyltransferase Inactivation by Ester Prodrugs of O6-Benzylguanine Derivatives and their Rate of Hydrolysis by Cellular Esterases
1998
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001
Effect of pulse parameters on the passive layer formation on pulse plated Ni–Co alloys
2006